|
AARD Aardvark Therapeutics Inc 1774857 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-21,588,000.00 |
| Balance Sheet |
|
Current Assets
|
$93,580,000.00 |
|
Assets
|
$98,590,000.00 |
|
Current Liabilities
|
$11,604,000.00 |
|
Liabilities
|
$11,604,000.00 |
|
Equity
|
$86,986,000.00 |
|
Shares Out
|
21816385.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,869,000.00 |
|
Investing Cash Flow
|
$34,250,000.00 |
| Market Analysis |
Market Cap
|
$139,624,864.00 |
|
Price
|
$6.80 |
|
BVPS
|
3.99 |
|
PB
|
1.60 |
|
EPS
|
-0.99 |
|
FCF
|
$-18,964,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:37 |
|
| Apr |
May |
Jun |
| 2026-03-23 |
-0.81 |
|
|
2026-05-07 |
-0.99 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.66 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.75 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AARD documents filed with the SEC.
AARD Filings
Clear
